Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
371 | 3500 | 28.1 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1175 | 8964 | TESTICULAR CANCER//TESTICULAR NEOPLASMS//SEMINOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TESTICULAR CANCER | Author keyword | 164 | 35% | 11% | 378 |
2 | RETROPERITONEAL LYMPH NODE DISSECTION | Author keyword | 133 | 81% | 2% | 79 |
3 | SEMINOMA | Author keyword | 102 | 33% | 7% | 254 |
4 | TESTICULAR NEOPLASMS | Author keyword | 82 | 33% | 6% | 204 |
5 | STAGE I SEMINOMA | Author keyword | 64 | 100% | 1% | 21 |
6 | GERM CELL TUMOR | Author keyword | 49 | 23% | 5% | 189 |
7 | GERM CELL CANCER | Author keyword | 45 | 59% | 1% | 51 |
8 | TESTIS CANCER | Author keyword | 42 | 46% | 2% | 68 |
9 | RESIDUAL TUMOR RESECTION | Author keyword | 35 | 89% | 0% | 16 |
10 | RPLND | Author keyword | 33 | 100% | 0% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TESTICULAR CANCER | 164 | 35% | 11% | 378 | Search TESTICULAR+CANCER | Search TESTICULAR+CANCER |
2 | RETROPERITONEAL LYMPH NODE DISSECTION | 133 | 81% | 2% | 79 | Search RETROPERITONEAL+LYMPH+NODE+DISSECTION | Search RETROPERITONEAL+LYMPH+NODE+DISSECTION |
3 | SEMINOMA | 102 | 33% | 7% | 254 | Search SEMINOMA | Search SEMINOMA |
4 | TESTICULAR NEOPLASMS | 82 | 33% | 6% | 204 | Search TESTICULAR+NEOPLASMS | Search TESTICULAR+NEOPLASMS |
5 | STAGE I SEMINOMA | 64 | 100% | 1% | 21 | Search STAGE+I+SEMINOMA | Search STAGE+I+SEMINOMA |
6 | GERM CELL TUMOR | 49 | 23% | 5% | 189 | Search GERM+CELL+TUMOR | Search GERM+CELL+TUMOR |
7 | GERM CELL CANCER | 45 | 59% | 1% | 51 | Search GERM+CELL+CANCER | Search GERM+CELL+CANCER |
8 | TESTIS CANCER | 42 | 46% | 2% | 68 | Search TESTIS+CANCER | Search TESTIS+CANCER |
9 | RESIDUAL TUMOR RESECTION | 35 | 89% | 0% | 16 | Search RESIDUAL+TUMOR+RESECTION | Search RESIDUAL+TUMOR+RESECTION |
10 | RPLND | 33 | 100% | 0% | 13 | Search RPLND | Search RPLND |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TESTIS CANCER | 417 | 74% | 9% | 311 |
2 | STAGE I SEMINOMA | 187 | 88% | 3% | 88 |
3 | GERM CELL TUMORS | 167 | 21% | 21% | 718 |
4 | TESTICULAR CANCER | 155 | 26% | 14% | 507 |
5 | NONSEMINOMATOUS TESTICULAR CANCER | 155 | 82% | 3% | 89 |
6 | SURVEILLANCE FOLLOWING ORCHIECTOMY | 115 | 89% | 1% | 51 |
7 | GROUP PROTOCOL | 106 | 95% | 1% | 36 |
8 | TESTICULAR SEMINOMA | 95 | 63% | 3% | 96 |
9 | NONSEMINOMATOUS TESTIS CANCER | 80 | 90% | 1% | 35 |
10 | MEDICAL RESEARCH COUNCIL | 79 | 54% | 3% | 102 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer | 2013 | 40 | 92 | 80% |
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part I | 2008 | 171 | 140 | 60% |
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II | 2008 | 94 | 130 | 96% |
Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience | 2015 | 3 | 54 | 94% |
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) | 2004 | 237 | 205 | 73% |
Testicular Cancer | 2009 | 43 | 33 | 94% |
Testicular germ-cell cancer | 2006 | 174 | 150 | 51% |
Medical treatment of advanced testicular cancer | 2008 | 108 | 189 | 67% |
Testicular germ-cell cancer | 1997 | 460 | 102 | 70% |
Testicular Cancer Clinical Practice Guidelines in Oncology | 2012 | 20 | 130 | 93% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONCOL HAEMATOL HAEMOSTASEOL | 8 | 100% | 0.1% | 5 |
2 | GENITOURINARY ONCOL SERV | 6 | 13% | 1.3% | 47 |
3 | KLIN INNERE MED HAMATOL ONKOL | 6 | 47% | 0.3% | 9 |
4 | AUO | 3 | 60% | 0.1% | 3 |
5 | CANC REGISTRY SLOVAK REPUBL | 3 | 60% | 0.1% | 3 |
6 | BIRMINGHAM ONCOL | 2 | 38% | 0.1% | 5 |
7 | BOB CHAMPION UNIT | 2 | 67% | 0.1% | 2 |
8 | HAMBURG MED | 2 | 67% | 0.1% | 2 |
9 | RADIOTHER IE RADIOONKOL | 2 | 67% | 0.1% | 2 |
10 | TESTIS SURG UNIT | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000275722 | EPIDIDYMAL MALAKOPLAKIA//INTRACARDIAC METASTASES//MAGNETIC RESONANCE IMAGING AND ANGIOGRAPHY |
2 | 0.0000174503 | TESTICULAR SELF EXAMINATION//TESTICULAR SELF EXAM//SELF EXAMINATION |
3 | 0.0000163032 | EXTRAGONADAL//MEDIASTINAL GERM CELL TUMOR//EXTRAGONADAL GERM CELL TUMOR |
4 | 0.0000143095 | SPERMATOCYTIC SEMINOMA//TESTICULAR CANCER//TESTICULAR INTRAEPITHELIAL NEOPLASIA |
5 | 0.0000098352 | GLIOMATOSIS PERITONEI//ENDODERMAL SINUS TUMOR//YOLK SAC TUMOR |
6 | 0.0000068177 | VASCULAR TOXICITY//INTERNAL MED PERIOPERAT ASSESSMENT//BOLUS 5 FLUOROURACIL |
7 | 0.0000043612 | LEYDIG CELL TUMOR//SERTOLI CELL TUMOR//LARGE CELL CALCIFYING SERTOLI CELL TUMOR |
8 | 0.0000043306 | FERTILITY PRESERVATION//OVARIAN TRANSPOSITION//GONADOTOXICITY |
9 | 0.0000037982 | PULMONARY TOXICITY//PULM DIS INTENS CARE//GEFITINIB IRESSA |
10 | 0.0000024612 | ETOPOSIDE PHOSPHATE//ETOPOSIDE//ORAL ETOPOSIDE |